SCHEMBL25699112

SCHEMBL25699112

Brc1ccc2c(c1)c1ccc([Si](c3ccccc3)(c3ccccc3)c3ccccc3)cc1n2-c1cccc([Si](c2ccccc2)(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ATM Q13315 1/20 0.37
LIG1 P18858 1/20 0.34
GABRA1 P14867 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA5 P31644 1/20 0.34
GABRA3 P34903 1/20 0.34
GABRA2 P47869 1/20 0.34
GABRA6 Q16445 1/20 0.34
MAT2A P31153 1/20 0.33
ALDH1A1 P00352 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
DNM1 Q05193 1/20 0.32
TSPO P30536 4/20 0.31
DCTPP1 Q9H773 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C19 P33261 1/20 0.31
OPRM1 P35372 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25806697 0.95 L3MBTL1 (0.42) L3MBTL1KDM4EATMLIG1GABRA1
SCHEMBL26543933 0.93 L3MBTL1 (0.38) L3MBTL1KDM4EATMLIG1GABRA1
SCHEMBL31624172 0.92 L3MBTL1 (0.46) L3MBTL1KDM4EATMLIG1GABRA1
SCHEMBL25699107 0.92 L3MBTL1 (0.46) L3MBTL1KDM4EATMLIG1GABRA1
SCHEMBL26426718 0.90 L3MBTL1 (0.44) L3MBTL1KDM4EATMLIG1GABRA1
SCHEMBL25831480 0.89 KDM4E (0.41) L3MBTL1KDM4EATMMAT2ADCTPP1
SCHEMBL346914 0.88 L3MBTL1 (0.42) L3MBTL1KDM4EATMLIG1GABRA1
SCHEMBL24064785 0.86 KDM4E (0.46) L3MBTL1KDM4EATM
SCHEMBL19870427 0.86 KDM4E (0.49) L3MBTL1KDM4EATMGABRA1GABRG2
SCHEMBL25699115 0.86 KDM4E (0.52) L3MBTL1KDM4EATMMAT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230192729-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-22 US disclosed
US-20230174559-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-08 US disclosed
US-20230174559-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND SAMSUNG DISPLAY CO., LTD. (KR) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174559-A1 LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND CRY1, CRY2, LAGE3 L3MBTL1 1696/4885KDM4E 2703/4885ATM 3571/4885
US-20230192729-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE LAGE3, EMC1, CYP2E1 L3MBTL1 1280/4885KDM4E 2517/4885ATM 3931/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.